This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dermatopolymyositis
M13_DERMATOPOLY
dermatomyositis: Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
512 |
4. Check minimum number of eventsNone |
512 |
5. Include endpoints |
551 |
6. Filter based on genotype QC (FinnGen only) |
535 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Dermato[poly]myositis
Similar endpoints
↥List of similar endpoints to
Dermatopolymyositis
based on the number of shared cases.
Similar with more cases:
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 535 | 333 | 202 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | 55.31 | 53.55 | 58.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 551
- Matched controls
- 5510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.2
ICD-10 Finland
Polymyositis
+∞
304.3
263
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.7
281.5
295
305
L04AX01
ATC
azathioprine; systemic
31.1
232.9
164
74
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
213.9
191
*
L04AX03
ATC
methotrexate; systemic
13.6
189.4
225
267
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
188.7
170
*
P01BA02
ATC
hydroxychloroquine; oral
13.1
163.3
188
210
G72.9
ICD-10 Finland
Myopathy, unspecified
54.9
145.9
84
18
L04AA06
ATC
mycophenolic acid; systemic
37.1
121.4
77
24
M60.9
ICD-10 Finland
Myositis, unspecified
193.2
119.8
121
8
H02AB06
ATC
prednisolone; systemic
8.2
103.2
444
1850
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
9.4
98.2
135
184
M05BA04
ATC
alendronic acid; oral
8.4
97.1
151
238
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.0
93.8
358
1308
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
54.9
87.2
50
10
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
428.8
76.8
75
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.5
76.1
110
157
NXL00
NOMESCO Finland
Biopsy of muscle
415.4
74.6
73
*
L01BA01
ATC
methotrexate; systemic
12.4
72.8
76
70
L04AD01
ATC
ciclosporin; systemic
20.1
67.2
53
29
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.2
66.1
134
272
H02AB07
ATC
prednisone; oral
5.2
61.5
160
404
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
122.5
61.3
65
6
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.7
59.7
82
109
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
87.3
56.3
62
8
M60.8
ICD-10 Finland
Other myositis
594.8
55.6
54
*
L04AA01
ATC
[U] ciclosporin
23.2
52.9
39
18
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
42.2
40
*
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
40.1
38
*
L88
ICPC
Rheumatoid/seropositive arthritis
7.5
38.9
59
87
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
38.7
333
1783
M05BA07
ATC
risedronic acid; oral
8.0
38.0
54
74
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.3
37.8
84
181
L99
ICPC
Musculoskeletal disease other
10.7
34.9
39
39
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
33.7
32
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9.7
32.5
39
43
M35.3
ICD-10 Finland
Polymyalgia rheumatica
10.4
32.4
37
38
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
9.6
31.6
38
42
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
29.4
216
1022
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
284.2
27.0
27
*
ZX120
NOMESCO Finland
Intravenous
3.7
25.1
90
277
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
24.1
23
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
22.9
107
389
XG410
NOMESCO Finland
Flow-volume spirometry
5.4
22.3
46
92
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
22.1
182
891
7104A
ICD-9 Finland
Diffuse diseases of connective tissue, Polymyositis
+∞
22.0
21
*
71610
ICD-8 Finland
Polymyositis and dermatomyositis, Polymyositis
+∞
22.0
21
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
27.7
21.6
29
11
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
52.2
21.3
25
5
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.8
21.0
40
74
XX9XE
NOMESCO Finland
Other ultrasound examination
23.5
20.6
29
13
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
20.3
143
645
R50.9
ICD-10 Finland
Fever, unspecified
2.9
20.3
115
464
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
20.3
157
742
L19
ICPC
Muscle symptom/complaint NOS
6.3
20.2
35
59
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.6
19.7
71
218
G72.8
ICD-10 Finland
Other specified myopathies
7.2
19.7
30
44
TGC00
NOMESCO Finland
Bronchial lavation
5.9
19.7
36
64
L28
ICPC
Limited function/disability (L)
2.7
19.4
131
577
XA402
NOMESCO Finland
ENMG
6.3
19.3
33
55
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
18.7
88
319
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
17.8
17
*
M33
ICD-10 Finland
Dermatopolymyositis
+∞
17.8
17
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.0
17.8
32
56
H02AB09
ATC
hydrocortisone; systemic
6.8
17.6
28
43
XPX04
NOMESCO Finland
Angioscopy
185.7
17.6
18
*
A02BC02
ATC
pantoprazole; systemic
2.3
16.9
399
2937
C03CA01
ATC
furosemide; systemic
2.2
16.7
202
1144
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.9
16.7
26
39
JN4BD
NOMESCO Finland
Extensive body CT
3.0
16.7
82
304
R13
ICD-10 Finland
Dysphagia
3.4
16.4
62
196
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
16.3
127
596
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
16.2
78
286
C08CA05
ATC
nifedipine; systemic
3.7
16.1
54
158
R4110
NOMESCO Finland
Physiotherapy
2.2
16.0
185
1026
R4120
NOMESCO Finland
Occupational therapy
3.4
15.3
58
184
D07AC01
ATC
betamethasone; topical
2.1
15.1
223
1354
E0000UV, ,
ATC
2.0
14.7
254
1630
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.4
14.7
56
178
71600
ICD-8 Finland
Polymyositis and dermatomyositis, Dermatomyositis
+∞
14.6
14
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
14.3
48
140
M05BX04
ATC
denosumab; parenteral
3.6
13.7
48
144
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
13.6
13
*
7103B
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS ADULTORUM]
+∞
13.6
13
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.7
13.5
32
72
N03AX16
ATC
[U] pregabalin
2.2
13.4
152
829
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
13.2
62
223
Z3226
NOMESCO Finland
Physiotherapist
2.2
13.1
129
664
R06.0
ICD-10 Finland
Dyspnoea
2.1
12.9
169
971
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
12.9
144
780
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
12.8
37
97
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
12.8
55
188
1XC02, ,
NOMESCO Finland
25.0
12.5
17
7
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
38.5
12.3
15
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
12.2
47
150
L29
ICPC
Musculoskeletal sympt/complt other
2.8
11.9
62
236
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
11.9
68
272
R4190
NOMESCO Finland
Nutritional therapy
4.1
11.7
33
85
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
11.6
48
160
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.7
11.3
26
57
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
11.2
58
220
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.1
11.2
31
79
XQ848
NOMESCO Finland
Dermatological photography
4.5
11.1
27
62
A07AA02
ATC
nystatin; oral
3.0
11.1
50
176
A28
ICPC
Limited function/disability NOS
2.2
10.9
106
540
UJF32
NOMESCO Finland
Coloscopy
2.0
10.7
155
916
L04AA13
ATC
[U] leflunomide
5.0
10.6
23
48
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.7
10.5
34
97
M60.0
ICD-10 Finland
Infective myositis
+∞
10.4
10
*
D07AB08
ATC
desonide; topical
2.4
10.4
78
355
H26.3
ICD-10 Finland
Drug-induced cataract
12.4
10.4
18
15
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
10.4
77
349
A02BC01
ATC
omeprazole; systemic
1.9
10.4
164
996
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.5
10.3
36
108
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.7
10.1
32
90
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
10.1
67
289
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
20.5
9.8
14
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
9.8
100
518
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
9.8
45
160
B07.9
ICD-10 Finland
Verruca simplex
3.9
9.7
29
78
J05AB01
ATC
aciclovir; systemic
2.0
9.7
136
792
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
9.5
44
157
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
9.5
142
843
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.3
9.4
19
37
N28
ICPC
Limited function/disability (N)
7.1
9.4
22
32
G72.4
ICD-10 Finland
Inflammatory myopathy, not elsewhere classified
+∞
9.4
9
*
R1250
NOMESCO Finland
Evaluation of functional capability
4.6
9.4
22
49
M05BA06
ATC
ibandronic acid; systemic
5.0
9.4
20
41
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.4
9.2
23
54
SPAT1229
SPAT
Assessment of need for aid
2.7
9.1
50
196
H05AA02
ATC
teriparatide; parenteral
15.9
9.1
14
9
E000001, ,
ATC
2.0
8.9
119
679
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
8.9
58
248
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
8.8
66
301
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
8.7
59
256
3015
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
14.3
8.7
14
10
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
14.3
8.7
14
10
TQW80
NOMESCO Finland
Local dermatologic skincare
4.5
8.7
21
48
318
Kela drug reimbursment
Teriparatide
16.6
8.6
13
8
5BA08, ,
NOMESCO Finland
16.6
8.6
13
8
L93.0
ICD-10 Finland
Discoid lupus erythematosus
16.6
8.6
13
8
M81.4
ICD-10 Finland
Drug-induced osteoporosis
20.4
8.5
12
6
H02AB04
ATC
methylprednisolone; systemic
2.1
8.4
89
466
M79.1
ICD-10 Finland
Myalgia
2.1
8.4
88
459
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
8.4
85
438
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
8.4
8
*
7103A
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS JUVENILIS]
+∞
8.4
8
*
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
+∞
8.4
8
*
EBA10
NOMESCO Finland
Operative extraction of tooth
2.2
8.4
71
341
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.7
8.3
16
17
Z50.1
ICD-10 Finland
Other physical therapy
2.8
8.3
42
158
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
8.3
77
384
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
11.9
8.1
14
12
XG466
NOMESCO Finland
Sleep oxymetry
3.7
8.1
25
69
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.3
8.1
31
99
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
8.1
161
1040
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.8
8.0
24
65
N99
ICPC
Neurological disease other
7.9
7.9
17
22
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
7.9
54
236
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
7.8
242
1760
294
Kela drug reimbursment
Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia
15.3
7.7
12
8
G71.08
ICD-10 Finland
Other muscular dystrophy
45.6
7.7
9
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.8
7.7
23
62
WX892
NOMESCO Finland
Monitored bed care
2.5
7.7
50
213
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
7.7
55
245
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.7
167
1103
K90.0
ICD-10 Finland
Coeliac disease
3.7
7.7
24
67
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.3
7.6
28
87
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
7.6
27
82
A02BC05
ATC
esomeprazole; systemic
1.7
7.6
225
1614
J01DB01
ATC
cefalexin; oral
1.9
7.6
446
3831
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
7.5
91
500
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
7.4
179
1214
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
7.4
50
217
C07AB07
ATC
bisoprolol; oral
1.6
7.4
266
2002
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.3
236
1726
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
7.3
7
*
M60.1
ICD-10 Finland
Interstitial myositis
+∞
7.3
7
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
J01MA12
ATC
levofloxacin; systemic
1.9
7.2
104
605
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
7.2
27
85
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
30.4
7.2
9
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
6.7
7.2
17
26
J01FF01
ATC
clindamycin; systemic
1.7
7.1
150
979
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
7.1
63
308
D07AC13
ATC
mometasone; topical
1.7
7.1
161
1073
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
8.9
7.1
14
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.1
217
1564
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
7.0
25
76
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.0
159
1058
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
7.0
99
573
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
14.0
6.9
11
8
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
14.0
6.9
11
8
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
6.8
47
206
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
9.5
6.8
13
14
JN4AD
NOMESCO Finland
Body CT examination
2.2
6.8
58
279
N06AA09
ATC
amitriptyline; systemic
2.2
6.8
61
300
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.9
6.8
32
116
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.1
6.7
28
94
RF420, ,
NOMESCO Finland
6.0
6.7
17
29
Z2221
NOMESCO Finland
Medical doctor
1.7
6.6
147
972
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.2
6.6
17
41
S18
ICPC
Laceration/cut
1.6
6.6
244
1833
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
6.6
42
178
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
6.5
59
290
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.5
158
1068
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.7
6.4
15
23
SBA10
NOMESCO Finland
Measurement of salivary flow rate
8.3
6.4
13
16
SPAT1254
SPAT
Administration of medicine
1.9
6.3
78
431
Z3231
NOMESCO Finland
Registered nurse
1.7
6.3
150
1008
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
6.3
81
454
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
6.3
6
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
6.3
6
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
27.0
6.2
8
*
6BA02, ,
NOMESCO Finland
27.0
6.2
8
*
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
27.0
6.2
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
6.2
24
77
J01DA01
ATC
[U] cefalexin
1.6
6.2
331
2690
HA1AA
NOMESCO Finland
X-ray mammography
2.2
6.2
54
262
XW000
NOMESCO Finland
Bone marrow biopsy
2.9
6.2
28
99
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
6.2
159
1090
R4110, ,
SPAT
2.2
6.2
52
249
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
7.8
6.2
13
17
A02BC03
ATC
lansoprazole; oral
1.6
6.1
159
1092
B01AC24
ATC
ticagrelor; oral
3.2
6.1
24
78
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.1
57
285
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.3
6.1
22
68
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.1
141
941
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
120
17
89.96
226.45
1.3
1.0
—
—
—
0
0
166
121
19.20
188.34
5.8
2.2
529.43
314.31
ug/l
0.46
160
114
403
1243
9.35
141.62
11.8
2.0
235.26
266.05
u/l
0.22
398
1174
113
80
17.51
128.27
1.7
1.1
50.04
—
u/ml
—
10
0
127
135
11.93
111.97
1.5
1.1
4.06
3.07
u/ml
—
8
6
116
123
11.68
102.07
2.0
1.3
—
—
—
0
0
102
104
11.81
91.87
1.5
1.1
12.35
3.80
u/ml
—
25
9
101
102
11.90
91.55
1.5
1.1
1.81
3.23
u/ml
—
13
6
66
8
93.62
60.45
1.2
1.0
—
—
—
0
0
74
88
9.56
58.87
1.4
1.1
54.47
7.02
u/ml
—
23
5
394
2030
4.30
55.45
17.0
5.7
2.61
2.83
%
1.60
386
1895
45
28
17.41
53.52
1.4
1.1
—
—
—
0
0
45
28
17.41
53.52
1.4
1.1
—
—
—
0
0
396
2093
4.17
52.58
17.0
5.8
26.22
28.08
%
2.97
389
1966
45
29
16.81
52.57
1.4
1.1
—
—
—
0
0
45
29
16.81
52.57
1.4
1.1
—
—
—
0
0
45
29
16.81
52.57
1.4
1.1
—
—
—
0
0
393
2070
4.13
52.36
16.5
5.5
59.16
57.07
%
2.80
386
1943
81
129
7.19
50.15
1.6
1.5
275.23
0.15
iu/ml
0.47
12
21
431
2506
4.31
47.66
19.4
9.2
4.19
4.07
e9/l
0.56
414
2208
127
389
3.94
36.46
1.8
2.0
351.54
382.63
nmol/l
0.39
120
360
337
1971
2.83
30.67
10.4
5.8
1.22
1.21
mmol/l
0.13
321
1787
196
869
2.95
30.31
2.0
1.4
2.24
2.43
g/l
0.59
150
515
30
25
12.63
30.10
1.5
1.2
2.20
—
u/ml
—
5
0
353
2152
2.78
28.99
11.9
6.6
1.22
1.21
mmol/l
0.36
311
1827
30
28
11.27
27.99
1.6
1.1
103.50
—
u/ml
—
8
0
305
1790
2.58
26.06
3.2
2.3
76.16
77.32
nmol/l
0.31
288
1590
456
3303
3.21
24.94
12.6
3.7
14.95
11.78
mm/h
4.87
443
3029
31
36
9.06
24.75
1.6
1.1
—
—
—
0
0
60
141
4.65
24.09
2.9
2.3
—
—
—
0
0
50
107
5.04
22.42
3.3
2.7
0.00
0.05
g/l
0.50
50
101
48
101
5.11
21.94
3.4
2.7
0.00
0.00
g/l
-0.00
48
95
48
101
5.11
21.94
3.4
2.7
0.00
0.00
g/l
-0.00
48
95
57
139
4.46
21.82
3.2
2.9
—
—
—
0
0
42
84
5.33
20.30
10.0
6.6
519.56
229.83
iu/ml
—
9
12
147
674
2.61
20.19
6.3
3.5
0.80
0.81
mmol/l
0.63
139
638
328
2144
2.31
20.03
5.2
3.6
0.00
0.00
estimate
0.50
69
438
259
1551
2.26
19.34
5.0
3.6
104.93
80.33
e6/l
0.16
190
1102
25
31
8.40
18.90
2.1
1.9
364.17
485.57
e6/l
0.61
18
23
328
2178
2.25
18.82
5.3
3.6
0.00
0.01
estimate
0.50
70
398
290
1840
2.22
18.53
7.3
4.6
34.12
35.66
g/l
4.09
280
1724
146
693
2.51
18.48
2.4
1.8
—
—
—
0
0
324
2153
2.23
18.39
7.0
4.9
0.00
0.00
estimate
-0.00
69
412
448
3422
2.65
18.25
16.5
7.2
73.88
78.52
u/l
1.17
443
3193
87
327
2.97
17.31
4.3
3.3
182.30
175.53
ng/l
0.06
78
303
216
1251
2.20
16.98
4.6
3.0
1072.92
1261.37
ng/l
0.43
197
1062
121
561
2.48
15.88
2.8
2.3
23.01
22.87
%
0.03
106
489
45
118
4.06
15.61
1.7
1.6
—
—
—
0
0
23
33
7.23
15.37
1.3
1.1
74.00
95.00
titre
—
10
6
140
704
2.33
15.26
1.4
1.2
59.10
36.65
iu/ml
0.63
44
228
27
23
12.28
15.21
2.3
2.2
—
—
—
0
0
35
79
4.66
14.69
1.5
1.4
—
—
—
0
0
164
897
2.18
14.50
3.2
2.4
2.84
5.74
e6/l
2.51
151
813
25
42
6.19
14.44
2.4
1.5
—
—
—
0
0
44
121
3.87
14.29
1.8
1.6
—
—
—
0
0
204
1219
2.07
14.26
4.3
3.0
0.25
0.47
e6/l
1.49
169
919
33
73
4.74
14.18
1.4
1.4
96.33
108.00
u/ml
—
6
13
44
122
3.83
14.13
1.3
1.2
—
—
—
0
0
35
83
4.44
13.82
1.8
1.6
—
—
—
0
0
35
83
4.44
13.82
1.8
1.6
—
—
—
0
0
216
1334
2.02
13.66
4.2
3.1
74.22
119.62
e6/l
0.25
180
1028
76
301
2.77
13.62
2.4
2.5
12.77
27.62
au/ml
—
6
18
34
81
4.41
13.35
1.2
1.4
—
—
—
0
0
105
493
2.40
13.23
2.3
1.8
—
—
—
0
0
172
991
2.07
13.07
1.4
1.2
0.97
1.69
u/ml
0.69
36
266
112
545
2.32
13.00
8.3
5.4
1.05
1.05
mmol/l
0.03
107
507
225
1434
1.96
12.81
6.4
3.2
47.69
31.21
u/l
3.12
215
1367
41
116
3.74
12.79
5.5
4.9
33.76
30.62
mg/l
0.14
34
93
177
1045
2.02
12.49
2.7
2.1
3.24
3.14
mg/l
0.21
159
887
32
77
4.35
12.41
1.2
1.5
289.90
263.07
u/ml
0.14
22
41
137
738
2.14
12.35
3.5
2.8
0.66
1.07
e6/l
2.27
93
413
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
34
87
4.10
12.18
1.7
1.5
—
—
—
0
0
40
116
3.64
12.04
5.6
4.9
44.32
118.91
mg/l
0.70
34
91
101
490
2.30
11.73
2.3
1.7
—
—
—
0
0
27
60
4.68
11.54
1.1
1.2
2.92
5.53
u/ml
0.30
12
19
31
78
4.15
11.35
5.0
3.3
61.19
58.96
%
0.38
31
78
30
74
4.23
11.27
4.6
3.0
4.49
4.61
e9/l
0.10
30
74
317
2324
1.86
11.24
8.8
6.2
9.93
11.24
umol/l
2.61
305
2192
33
90
3.84
10.85
1.8
1.6
—
—
—
0
0
23
30
7.95
10.48
2.2
1.9
0.18
0.23
e9/l
0.47
18
23
22
46
4.94
10.09
1.0
1.1
—
—
—
0
0
21
26
8.35
9.91
2.2
2.8
47.83
41.12
%
0.63
12
13
69
307
2.43
9.69
2.1
1.6
—
—
—
0
0
123
695
1.99
9.51
1.3
1.2
31.94
14.68
u/ml
0.50
35
267
259
1853
1.75
9.35
3.6
2.7
184.13
118.21
ug/l
2.16
246
1705
25
63
4.11
9.15
1.4
1.5
—
—
—
0
0
278
2040
1.73
9.08
16.8
13.4
1.27
1.24
inr
0.17
73
614
73
344
2.29
8.99
2.8
2.3
18.27
6.55
ug/l
2.58
64
301
216
1480
1.76
8.98
3.5
3.4
2.33
2.36
mmol/l
1.90
199
1306
13
7
18.97
8.97
1.8
2.3
—
—
—
0
0
139
834
1.89
8.95
6.1
3.9
237.73
234.59
ng/l
0.01
119
645
93
485
2.10
8.91
13.2
6.9
10.54
12.32
kpa
3.58
83
469
93
485
2.10
8.91
13.3
6.9
5.20
5.10
kpa
0.42
83
467
366
2911
1.77
8.87
6.2
4.4
15.40
2534.38
e6/l
—
5
48
22
52
4.37
8.73
1.2
1.4
—
—
—
0
0
26
70
3.85
8.71
2.0
1.5
—
—
—
0
0
131
778
1.90
8.68
1.8
1.7
1142.26
1189.38
nmol/l
0.24
107
589
25
66
3.92
8.60
2.0
1.5
—
—
—
0
0
21
49
4.42
8.47
1.7
1.9
—
—
—
0
0
22
54
4.20
8.33
1.7
1.8
—
—
—
0
0
91
485
2.05
8.21
13.5
6.9
1.54
1.13
mmol/l
0.33
70
391
159
1020
1.79
8.16
1.6
1.5
19.43
21.19
nmol/l
0.91
140
861
197
1345
1.72
8.12
2.7
2.4
54.08
60.25
u/l
0.85
182
1238
26
74
3.64
8.06
1.3
1.5
—
—
—
0
0
24
65
3.81
7.98
1.1
1.2
2.44
4.45
u/ml
—
9
31
168
1110
1.74
7.72
4.0
2.6
2638.35
7794.36
umol/l
1.18
155
967
20
50
4.11
7.40
1.3
1.4
20.73
65.00
%
3.73
11
36
322
2550
1.63
7.19
8.9
4.6
6.63
6.70
mmol/l
0.27
310
2381
89
496
1.95
7.04
3.3
3.0
6.35
8.35
umol/l
0.88
76
434
114
691
1.82
6.96
3.8
2.9
3.26
2.31
e6/l
0.62
72
371
18
45
4.10
6.67
1.8
2.2
—
—
—
0
0
17
30
5.81
6.50
1.1
1.3
—
—
—
0
0
167
1159
1.63
6.17
6.4
3.8
0.00
0.00
estimate
-0.00
69
406
20
58
3.54
6.06
2.1
1.5
—
—
—
0
0
11
11
10.17
6.05
1.9
1.3
8.37
8.22
ug/l
0.05
11
11
9
6
15.21
5.92
1.1
1.3
—
—
—
0
0
223
1672
1.56
5.89
5.3
3.5
91.89
36.60
ng/l
2.33
189
1152
13
19
6.98
5.76
2.0
1.3
—
—
—
0
0
14
23
6.22
5.72
1.0
1.2
—
—
—
0
0
157
1095
1.61
5.61
6.6
3.7
91.44
91.91
%
0.08
150
1069
28
105
2.76
5.58
1.2
1.6
—
—
—
0
0
12
18
6.79
5.28
1.0
1.1
1.06
1.06
ratio
—
6
6
218
1659
1.52
5.23
5.8
3.7
—
—
—
0
0
29
115
2.61
5.21
1.4
1.3
—
—
—
0
0
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
228
1768
1.49
4.92
2.2
2.0
94.65
94.55
pmol/l
0.01
127
894
23
84
2.81
4.83
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
121
2.47
4.72
4.9
2.5
0.37
0.37
u/ml
0.04
19
62
14
30
4.76
4.71
1.6
3.2
—
—
—
0
0
24
92
2.68
4.62
2.5
1.4
—
—
—
0
0
11
18
6.21
4.62
1.7
3.3
1187.09
1040.94
u/ml
0.16
11
18
138
974
1.56
4.58
2.2
1.8
1.26
1.14
mg/l
0.25
103
765
15
37
4.14
4.43
1.1
1.0
—
—
—
0
0
9
12
7.60
4.37
1.1
1.1
—
—
—
0
0
14
33
4.33
4.35
1.0
1.1
—
—
—
0
0
31
139
2.30
4.33
1.4
1.1
—
—
—
0
0
46
243
1.97
4.26
2.0
1.7
—
—
—
0
0
10
17
5.97
4.14
1.0
1.1
—
—
—
0
0
23
92
2.57
4.10
1.5
1.2
—
—
—
0
0
23
92
2.57
4.10
1.5
1.2
—
—
—
0
0
30
137
2.26
4.03
1.3
1.1
—
—
—
0
0
482
4447
1.67
3.89
31.4
13.1
19.30
22.98
mg/l
2.39
444
3486
7
8
8.84
3.78
1.0
1.0
—
—
—
0
0
125
906
1.49
3.60
1.6
1.8
59829499.72
6667103.97
pmol/l
0.42
117
750
24
105
2.34
3.57
1.6
1.6
4187.22
18923.42
e6/l
1.52
18
76
9
17
5.36
3.52
3.3
1.7
61.56
55.19
ug/l
—
9
17
63
391
1.69
3.50
6.0
4.3
2.13
1.95
mmol/l
0.17
56
326
115
829
1.49
3.39
2.4
2.9
2.47
2.45
mmol/l
0.92
97
739
8
14
5.78
3.35
1.3
1.6
—
—
—
0
0
66
420
1.65
3.34
2.4
2.3
355.32
33.96
u/l
0.49
56
355
127
938
1.46
3.31
6.7
3.9
1.02
1.02
kg/l
0.03
20
138
32
164
2.01
3.26
2.7
1.9
—
—
—
0
0
9
19
4.80
3.25
1.0
1.1
90.72
213.04
iu/ml
—
9
19
17
66
2.63
3.24
1.1
1.1
—
—
—
0
0
330
2884
1.36
3.08
4.1
3.1
54.46
46.26
u/l
1.00
316
2686
26
126
2.12
3.07
1.6
1.3
—
—
—
0
0
38
216
1.82
2.88
1.0
1.0
—
—
—
0
0
7
13
5.44
2.87
2.0
2.8
37814.29
35077.31
ug/l
—
7
13
12
38
3.20
2.86
1.3
1.3
—
—
—
0
0
43
255
1.74
2.84
1.6
1.4
—
—
—
0
0
10
28
3.62
2.79
1.2
1.2
63.90
32.84
mg/l
—
10
23
10
28
3.62
2.79
1.0
1.1
304.00
284.48
mg/l
—
10
23
39
232
1.73
2.56
1.4
1.3
—
—
—
0
0
5
7
7.20
2.55
3.8
1.4
—
—
—
0
0
9
26
3.50
2.49
1.0
1.0
—
—
—
0
0
19
371
0.49
2.44
1.7
1.7
—
—
—
0
0
8
22
3.67
2.37
1.5
1.1
—
—
—
0
0
41
254
1.66
2.35
3.3
3.0
4.20
4.56
pmol/l
1.83
35
220
8
23
3.51
2.27
1.3
1.3
—
—
—
0
0
8
23
3.51
2.27
1.3
1.3
—
—
—
0
0
407
4354
0.75
2.23
4.9
4.4
1.40
1.49
mmol/l
4.80
384
4014
27
151
1.83
2.20
2.5
1.7
—
—
—
0
0
14
61
2.33
2.16
1.0
1.1
—
—
—
0
0
13
55
2.40
2.13
3.4
1.7
90.52
89.65
%
0.31
13
55
411
4381
0.76
2.10
4.9
4.5
4.79
4.69
mmol/l
1.32
387
4051
10
37
2.73
2.08
1.9
1.1
2.00
1.51
nmol/l
—
10
32
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
7
20
3.53
2.06
1.1
1.0
—
—
—
0
0
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
391
4188
0.77
2.00
4.5
4.0
1.53
1.28
mmol/l
4.22
369
3838
24
134
1.83
1.98
1.3
1.4
300.94
294.50
ug/g
0.06
16
82
19
98
1.97
1.97
1.4
1.6
4.41
5.95
iu/l
—
8
29
10
39
2.59
1.95
1.5
1.5
—
—
—
0
0
5
11
4.58
1.94
2.0
1.4
—
—
—
0
0
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
422
4465
0.77
1.86
5.2
5.0
2.88
2.77
mmol/l
1.77
401
4109
23
130
1.80
1.84
1.3
1.5
—
—
—
0
0
5
12
4.19
1.82
1.2
1.3
—
—
—
0
0
13
60
2.19
1.79
1.2
1.1
—
—
—
0
0
368
3390
1.26
1.76
4.9
3.9
14.94
14.79
pmol/l
0.59
345
3060
6
18
3.36
1.75
2.0
1.3
—
—
—
0
0
6
19
3.18
1.66
2.5
1.7
—
—
—
0
0
6
19
3.18
1.66
2.5
1.7
—
—
—
0
0
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
10
41
2.47
1.65
1.3
1.2
—
—
—
0
0
151
1268
1.26
1.63
3.3
3.2
2193.45
105.47
mg/l
1.53
105
801
235
2076
1.23
1.61
3.3
2.5
—
—
—
0
0
18
99
1.85
1.59
1.4
1.5
—
—
—
0
0
6
20
3.02
1.58
1.0
1.5
—
—
—
0
0
7
27
2.61
1.52
1.6
1.4
—
—
—
0
0
7
27
2.61
1.52
1.6
1.4
—
—
—
0
0
9
37
2.46
1.48
3.6
3.1
—
—
—
0
0
10
45
2.24
1.47
1.2
1.0
—
—
—
0
0
7
28
2.52
1.45
2.1
1.4
0.96
1.02
g/l
—
7
28
11
52
2.14
1.45
1.4
1.2
—
—
—
0
0
5
16
3.14
1.44
1.0
1.0
1323.80
1259.38
miu/ml
—
5
16
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
6
22
2.75
1.44
2.5
1.6
—
—
—
0
0
6
22
2.75
1.44
2.5
1.6
—
—
—
0
0
62
470
1.36
1.42
2.4
4.2
3.13
36.48
ug/l
1.21
49
389
14
74
1.92
1.40
1.4
1.3
—
—
—
0
0
60
456
1.35
1.36
5.2
3.2
—
—
—
0
0
20
120
1.69
1.36
2.1
1.5
—
—
—
0
0
9
45
2.02
1.24
4.0
3.3
—
—
—
0
0
156
1363
1.20
1.14
3.1
3.2
6.91
7.40
mmol/l
0.71
137
1139
7
30
2.35
1.12
1.1
1.3
—
24.00
—
0
5
427
4077
1.21
1.09
5.7
4.7
1.90
2.20
mu/l
0.50
405
3713
5
22
2.28
1.03
1.2
1.5
1.82
1.59
g/l
—
5
22
7
34
2.07
1.03
1.6
1.4
—
—
—
0
0
21
140
1.52
0.99
1.5
1.6
—
—
—
0
0
10
54
1.87
0.97
1.7
1.7
—
—
—
0
0
10
54
1.87
0.97
1.7
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
27
2.24
0.93
1.2
1.2
—
—
—
0
0
10
55
1.83
0.92
1.7
1.7
—
—
—
0
0
10
55
1.83
0.92
1.7
1.7
—
—
—
0
0
10
55
1.83
0.92
1.7
1.7
—
—
—
0
0
10
55
1.83
0.92
1.7
1.7
—
—
—
0
0
120
1050
1.18
0.86
2.7
2.2
—
—
—
0
0
90
774
1.19
0.79
1.5
1.5
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
31
403
0.76
0.77
2.7
1.8
—
—
—
0
0
9
54
1.68
0.75
1.2
1.1
—
—
—
0
0
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
25
185
1.37
0.73
2.7
3.2
20.35
1845.39
u/ml
1.11
20
158
148
1338
1.15
0.70
3.6
3.8
7.19
8.41
mg/mmol
0.20
92
830
14
94
1.50
0.67
3.2
2.2
114.00
132.47
g/l
—
7
70
24
180
1.35
0.66
7.6
5.1
2.05
1.57
%
2.29
19
170
14
99
1.42
0.54
3.0
3.7
31.71
26.98
mg/l
—
8
59
59
510
1.18
0.52
1.4
1.7
1.48
1.45
%
0.14
48
452
6
40
1.51
0.51
2.0
2.2
13.67
13.16
%
—
6
40
6
40
1.51
0.51
3.0
3.2
7.62
6.51
nmol/l
—
6
40
42
353
1.21
0.51
2.7
2.7
69.62
67.78
ml/min/173m2
0.06
13
152
13
92
1.42
0.51
4.2
2.3
15.22
16.55
%
—
5
46
483
4740
1.15
0.49
25.0
10.1
30.82
25.72
u/l
6.98
476
4563
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
466
4567
1.13
0.46
30.0
15.6
139.36
139.71
mmol/l
2.00
456
4446
13
95
1.38
0.44
1.1
1.3
—
—
—
0
0
420
4296
0.91
0.42
4.9
4.5
5.73
5.95
mmol/l
3.72
392
3913
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
38
442
0.85
0.40
2.4
2.0
—
—
—
0
0
10
71
1.42
0.39
1.2
1.5
—
—
—
0
0
19
151
1.27
0.39
1.9
1.7
—
—
—
0
0
466
4583
1.11
0.36
30.3
15.7
3.94
3.97
mmol/l
2.29
456
4450
34
292
1.18
0.35
1.3
1.2
96.09
127.37
iu/ml
—
8
112
430
4216
1.09
0.35
24.1
12.6
86.29
81.28
ml/min/173m2
3.91
381
3453
9
119
0.75
0.27
1.4
1.2
—
—
—
0
0
76
711
1.08
0.22
1.6
1.4
—
—
—
0
0
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
129
1232
1.06
0.22
1.7
1.7
1.64
1.37
mmol/l
2.16
111
1038
406
4116
0.95
0.20
6.4
5.7
40.03
39.80
mmol/mol
0.21
387
3816
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
2.0
2.6
—
22.69
—
0
15
125
1203
1.05
0.17
4.6
4.9
3.75
2.36
ug/l
0.65
114
1083
92
963
0.95
0.16
3.6
4.4
22.58
21.52
%
0.32
45
454
491
4943
0.94
0.15
42.9
19.9
4.37
4.48
e12/l
5.24
483
4807
13
150
0.86
0.15
1.4
1.5
—
—
—
0
0
491
4940
0.94
0.13
44.2
20.0
39.68
41.08
%
0.79
453
4621
491
4939
0.95
0.12
43.0
20.0
261.68
250.02
e9/l
2.30
484
4813
59
563
1.05
0.11
4.9
4.5
30.60
31.76
%
0.42
47
368
5
62
0.80
0.08
1.6
1.3
7.84
7.34
mmol/l
—
5
51
7
66
1.06
0.08
2.1
1.7
—
—
—
0
0
8
93
0.86
0.06
1.4
1.5
—
—
—
0
0
12
110
1.09
0.05
1.8
2.4
13609.18
2884.99
u/l
—
6
37
16
171
0.93
0.05
2.1
1.8
—
—
—
0
0
10
92
1.09
0.03
1.6
1.7
—
—
—
0
0
53
538
0.98
0.01
9.4
6.3
—
—
—
0
0
272
2711
1.01
0.01
3.2
2.9
—
—
—
0
0
13
136
0.95
0.00
1.8
1.4
—
—
—
0
0
71
706
1.01
0.00
2.7
3.0
0.73
0.75
ug/l
0.14
48
460
22
222
0.99
0.00
2.0
1.9
—
—
—
0
0
6
65
0.92
0.00
1.3
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
39.33
—
0
6
0
5
0.00
-0.00
0.0
4.8
—
8.10
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
12.54
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
54
0.93
-0.00
1.4
1.5
31.30
28.71
u/l
—
5
45
0
5
0.00
-0.00
0.0
3.4
—
67.44
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: M13_DERMATOPOLY – Dermatopolymyositis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).